Association Analysis of Free Thyroid Hormones, Subclinical Hypothyroidism, and Thyroid Peroxidase Antibody in the First Trimester with Gestational Diabetes Mellitus

IF 0.4 4区 医学 Q4 OBSTETRICS & GYNECOLOGY
Yi Zhou, Yang Dong
{"title":"Association Analysis of Free Thyroid Hormones, Subclinical Hypothyroidism, and Thyroid Peroxidase Antibody in the First Trimester with Gestational Diabetes Mellitus","authors":"Yi Zhou, Yang Dong","doi":"10.31083/j.ceog5009192","DOIUrl":null,"url":null,"abstract":"Background: We aimed to investigate the association of free thyroxin (FT4), free triiodothyronine (FT3), subclinical hypothyroidism (SCH), and thyroid peroxidase antibody (TPOab) in the first trimester with gestational diabetes mellitus (GDM). Methods: We recruited 110 pregnant women with GDM and 100 pregnant women without GDM who had normal 75 g oral glucose tolerance test (OGTT) results between June 2019 and June 2021. We collected basic data from all participants and compared serum FT3 and FT4 levels, SCH, and TPOab (+) incidences in the first trimester between the two groups. We used logistic regression to identify factors that influence the development of GDM. Results: Serum FT3 levels were 4.58 ± 0.78 and 4.61 ±1.42 pmol/L in the GDM group and Control group, while FT4 levels were 9.32 ± 2.54 and 10.24 ± 2.77 pmol/L. The incidence of SCH were 25.5% and 14.0%, while TPO (+) were 20.0% and 10.0%. The GDM group’s FT4 levels were significantly lower than the control group’s, whereas the GDM group’s age, incidence of SCH, and TPOab (+) were significantly higher (p < 0.05). Logistic regression analysis demonstrated that age, SCH and TPO (+) were risk factors for GDM (p < 0.05), the regression equation: logit p = –3.484 + 0.105 (age) + 1.128 (SCH) + 1.294 (TPOab (+)). Conclusions: Our findings suggest that monitoring the changes in FT4 levels, SCH, and TPOab (+) incidence in the first trimester may be useful in predicting the occurrence and development of GDM.","PeriodicalId":10312,"journal":{"name":"Clinical and experimental obstetrics & gynecology","volume":null,"pages":null},"PeriodicalIF":0.4000,"publicationDate":"2023-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and experimental obstetrics & gynecology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31083/j.ceog5009192","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: We aimed to investigate the association of free thyroxin (FT4), free triiodothyronine (FT3), subclinical hypothyroidism (SCH), and thyroid peroxidase antibody (TPOab) in the first trimester with gestational diabetes mellitus (GDM). Methods: We recruited 110 pregnant women with GDM and 100 pregnant women without GDM who had normal 75 g oral glucose tolerance test (OGTT) results between June 2019 and June 2021. We collected basic data from all participants and compared serum FT3 and FT4 levels, SCH, and TPOab (+) incidences in the first trimester between the two groups. We used logistic regression to identify factors that influence the development of GDM. Results: Serum FT3 levels were 4.58 ± 0.78 and 4.61 ±1.42 pmol/L in the GDM group and Control group, while FT4 levels were 9.32 ± 2.54 and 10.24 ± 2.77 pmol/L. The incidence of SCH were 25.5% and 14.0%, while TPO (+) were 20.0% and 10.0%. The GDM group’s FT4 levels were significantly lower than the control group’s, whereas the GDM group’s age, incidence of SCH, and TPOab (+) were significantly higher (p < 0.05). Logistic regression analysis demonstrated that age, SCH and TPO (+) were risk factors for GDM (p < 0.05), the regression equation: logit p = –3.484 + 0.105 (age) + 1.128 (SCH) + 1.294 (TPOab (+)). Conclusions: Our findings suggest that monitoring the changes in FT4 levels, SCH, and TPOab (+) incidence in the first trimester may be useful in predicting the occurrence and development of GDM.
妊娠早期游离甲状腺激素、亚临床甲状腺功能减退、甲状腺过氧化物酶抗体与妊娠糖尿病的相关性分析
背景:我们旨在研究妊娠早期游离甲状腺素(FT4)、游离三碘甲状腺原氨酸(FT3)、亚临床甲状腺功能减退(SCH)和甲状腺过氧化物酶抗体(TPOab)与妊娠糖尿病(GDM)的关系。方法:我们招募了110名GDM孕妇和100名非GDM孕妇,这些孕妇在2019年6月至2021年6月期间75 g口服葡萄糖耐量试验(OGTT)结果正常。我们收集了所有参与者的基本数据,并比较了两组妊娠早期血清FT3和FT4水平、SCH和TPOab(+)发生率。我们使用逻辑回归来确定影响GDM发展的因素。结果:GDM组和对照组血清FT3水平分别为4.58±0.78和4.61±1.42 pmol/L, FT4水平分别为9.32±2.54和10.24±2.77 pmol/L。SCH发生率分别为25.5%和14.0%,TPO(+)发生率分别为20.0%和10.0%。GDM组FT4水平显著低于对照组,而GDM组年龄、SCH发生率、TPOab(+)均显著高于对照组(p <0.05)。Logistic回归分析显示,年龄、SCH和TPO(+)是GDM的危险因素(p <0.05),回归方程:logit p = -3.484 + 0.105 (age) + 1.128 (SCH) + 1.294 (TPOab(+))。结论:我们的研究结果表明,在妊娠早期监测FT4水平、SCH和TPOab(+)发生率的变化可能有助于预测GDM的发生和发展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.50
自引率
0.00%
发文量
241
审稿时长
1 months
期刊介绍: CEOG is an international, peer-reviewed, open access journal. CEOG covers all aspects of Obstetrics and Gynecology, including obstetrics, prenatal diagnosis, maternal-fetal medicine, perinatology, general gynecology, gynecologic oncology, uro-gynecology, reproductive medicine, infertility, reproductive endocrinology, sexual medicine. All submissions of cutting-edge advances of medical research in the area of women''s health worldwide are encouraged.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信